Is Herd Immunity Against SARS-CoV-2 a Silver Lining?

Front Immunol. 2020 Sep 30:11:586781. doi: 10.3389/fimmu.2020.586781. eCollection 2020.

Ramachandran Vignesh^{1

2}, Esaki M Shankar³, Vijayakumar Velu^{4

5}, Sadras Panchatcharam Thyagarajan⁶

¹ Preclinical Department, Royal College of Medicine Perak (UniKL RCMP), Universiti Kuala Lumpur, Ipoh, Malaysia.
² Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Chennai, India.
³ Infection Biology, Department of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India.
⁴ Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States.
⁵ Department of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory University, Atlanta, GA, United States.
⁶ Central Research Facility, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.

No abstract available

Keywords: coronavirus disease 2019; herd immunity; seroprevalence; severe acute respiratory syndrome coronavirus-2; vaccines.

Publication types